Xact Kapitalforvaltning’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.02M Hold
5,551
0.02% 500
2019
Q4
$927K Hold
5,551
0.02% 648
2019
Q3
$727K Hold
5,551
0.01% 718
2019
Q2
$674K Hold
5,551
0.01% 757
2019
Q1
$684K Hold
5,551
0.02% 733
2018
Q4
$650K Buy
5,551
+700
+14% +$82.5K 0.02% 719
2018
Q3
$606K Hold
4,851
0.01% 829
2018
Q2
$415K Buy
4,851
+600
+14% +$44.1K 0.01% 1083
2018
Q1
$257K Buy
+4,251
New +$242K 0.01% 1339

Other funds holding AMED

Xact Kapitalforvaltning's AMED Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Amedisys (AMED) position steady in Q1 2020 at 5,551 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #500.

Xact Kapitalforvaltning first reported a position in AMED in Q1 2018 and has held it in 9 quarters since. 333 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Xact Kapitalforvaltning held 5,551 shares of Amedisys worth $1.02M as of Q1 2020.
  • Xact Kapitalforvaltning left its Amedisys share count unchanged in Q1 2020.
  • Amedisys made up 0.02% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #500 holding.
  • Xact Kapitalforvaltning first reported a position in Amedisys in Q1 2018 and has held it in 9 quarters since.
  • 333 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.